The trusted source for
healthcare information and
Provided by Relias Learning, LLC
Release date: July 25, 2017
Valid through: July 25, 2018
Estimated Time to Complete Activity: 120 minutes
Anyone involved with or interested in compliance regulations and standards, including but not limited to: CEOs, CFOs, COOs, CMOs, CNOs, CE Directors, Department Directors, Quality Improvement Staff, Physicians, Nurses (all levels), Compliance Officers, CMS Liaisons, TJC Liaisons, Registration Staff, Safety Officers and Staff, Pharmacy Staff, Ethics Committee Members, Consumer Advocates, Risk Managers, Legal Counsel, Behavioral Health Staff, Psychiatry Staff, Social Workers, Discharge Planners, Case Managers, Hospice Staff and Regulatory Affairs Staff.
CMS proposed significant changes to the hospital CoPs for both standard and critical access hospitals. These changes affect nursing, medical record, infection control, QAPI, patients' rights, and restraint and seclusion CoPs. Our expert will discuss all of the proposed changes to the hospital CoPs and review the antibiotic stewardship program hospitals are required to implement.
After this presentation attendees will be able to:
Relias Learning, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity has been approved for 2.0 nursing contact hour(s) using a 60-minute contact hour.
Provider approved by the California Board of Registered Nursing, Provider # CEP13791 for 2.0 Contact Hour(s).
This activity is valid July 25, 2017, through July 25, 2018.
Sue Dill Calloway, RN, MSN, JD
Sue is a nurse attorney, medico-legal consultant and long-time educator for nurses, physicians, and other healthcare providers. She is a frequent speaker and is well known across the country in the areas of healthcare law, risk management, and patient safety. She has authored over 100 books and hundreds of articles. For AHC Media, she authored the book Cracking the Code: Understanding the CMS Hospital CoP Standards on Anesthesia.
Ms. Calloway received her Bachelor of Arts, Bachelor of Science in Nursing, Master of Science in Nursing, and Doctor of Jurisprudence from Capital University in Columbus, Ohio. Additionally, she is certified in healthcare risk management by the American Society for Healthcare Risk Management and is the first in the country to be certified in CMS regulatory compliance.
It is the policy of Relias Learning that all faculty participating in continuing education activities disclose to the audience in advance of the activity any consultant, stockholder, speakers’ bureau, research, or other financial relationships with companies having ties to this field of study. We disclose that Sue Dill Calloway, RN, MSN, JD, and Lead Nurse Planner Amy Johnson report no relevant financial relationships related to the material presented in this webinar.
Mention of products or services in this webinar does not constitute endorsement. Clinical, legal, tax, and other comments are offered for general guidance only; professional counsel should be sought for specific situations.
During the accredited period, participants must read the learning objectives and faculty disclosures; study the educational activity; and complete the evaluation form. If you complete the evaluation, your certificate will be available immediately for download in PDF format.
Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. You will need a PDF viewer such as Adobe Reader to view PDF files.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.